Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Utility of Ki-67, p53, Bcl-2, and Cox-2 biomarkers for low-grade endometrial cancer and disordered proliferative/benign hyperplastic endometrium by imprint cytology.

Apostolou G, Apostolou N, Biteli M, Kavantzas N, Patsouris E, Athanassiadou P.

Diagn Cytopathol. 2014 Feb;42(2):134-42. doi: 10.1002/dc.23010. Epub 2013 Jun 1.

PMID:
23729350
3.

Cytodiagnosis of endometrial carcinoma and hyperplasia on imprint smears with additional immunocytochemistry using Ki-67 and p53 biomarkers.

Apostolou G, Apostolou N, Nikolaidou C, Kavantzas N, Patsouris E, Athanassiadou P.

Cytopathology. 2014 Apr;25(2):86-94. doi: 10.1111/cyt.12095. Epub 2013 Oct 14.

PMID:
24118263
5.
6.

bcl-2 protein expression in endometrial carcinoma: the lack of correlation with p53.

Miturski R, Semczuk A, Tomaszewski J, Jakowicki J.

Cancer Lett. 1998 Nov 13;133(1):63-9.

PMID:
9929161
7.

Supervised clustering of immunohistochemical markers to distinguish atypical endometrial hyperplasia from grade 1 endometrial cancer.

Laas E, Ballester M, Cortez A, Gonin J, Daraï E, Graesslin O.

Gynecol Oncol. 2014 May;133(2):205-10. doi: 10.1016/j.ygyno.2014.02.018. Epub 2014 Feb 17.

PMID:
24556060
8.

Dissociated expression of Bcl-2 and Ki-67 in endometrial lesions: diagnostic and histogenetic implications.

Risberg B, Karlsson K, Abeler V, Lagrelius A, Davidson B, Karlsson MG.

Int J Gynecol Pathol. 2002 Apr;21(2):155-60.

PMID:
11917225
9.

L-type amino acid transporter 1 expression increases in well-differentiated but decreases in poorly differentiated endometrial endometrioid adenocarcinoma and shows an inverse correlation with p53 expression.

Watanabe J, Yokoyama Y, Futagami M, Mizunuma H, Yoshioka H, Washiya K, Hana K, Endou H, Okayasu I.

Int J Gynecol Cancer. 2014 May;24(4):659-63. doi: 10.1097/IGC.0000000000000123.

PMID:
24694899
10.

Bcl-2, iNOS, p53 and PCNA expression in normal, disordered proliferative, hyperplastic and malignant endometrium.

Cinel L, Polat A, Aydin O, Düşmez D, Eğilmez R.

Pathol Int. 2002 May-Jun;52(5-6):384-9.

PMID:
12100521
11.

Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.

Buell-Gutbrod R, Cavallo A, Lee N, Montag A, Gwin K.

Int J Gynecol Pathol. 2015 Jan;34(1):65-73. doi: 10.1097/PGP.0000000000000106.

PMID:
25473755
12.

The patterns of expression of an apoptosis-related CK18 neoepitope, the bcl-2 proto-oncogene, and the Ki67 proliferation marker in normal, hyperplastic, and malignant endometrium.

Morsi HM, Leers MP, Jäger W, Björklund V, Radespiel-Tröger M, el Kabarity H, Nap M, Lang N.

Int J Gynecol Pathol. 2000 Apr;19(2):118-26.

PMID:
10782407
13.

Is the immunohistochemical expression of proliferation (Ki-67) and apoptosis (Bcl-2) markers and cyclooxigenase-2 (COX-2) related to carcinogenesis in postmenopausal endometrial polyps?

Antunes A Jr, Andrade LA, Pinto GA, Leão R, Pinto-Neto AM, Costa-Paiva L.

Anal Quant Cytopathol Histpathol. 2012 Oct;34(5):264-72.

PMID:
23301386
14.

Ki-67, p53 and bcl-2 analysis in colonic versus rectal adenocarcinoma.

Petrişor O, Giuşcă SE, Sajin M, Dobrescu G, Căruntu ID.

Rom J Morphol Embryol. 2008;49(2):163-71.

15.

Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables.

Ozuysal S, Oztürk H, Bilgin T, Filiz G.

Arch Gynecol Obstet. 2005 Feb;271(2):123-6. Epub 2004 Jan 23.

PMID:
14740230
17.

Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium.

Halperin R, Zehavi S, Habler L, Hadas E, Bukovsky I, Schneider D.

Eur J Gynaecol Oncol. 2001;22(2):122-6.

PMID:
11446475
18.

Diagnostic utility of phosphatase and tensin homolog, beta-catenin, and p53 for endometrial carcinoma by thin-layer endometrial preparations.

Norimatsu Y, Miyamoto M, Kobayashi TK, Moriya T, Shimizu K, Yanoh K, Tsukayama C, Miyake Y, Ohno E.

Cancer. 2008 Jun 25;114(3):155-64. doi: 10.1002/cncr.23495.

19.

Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance.

Sivridis E, Giatromanolaki A, Koukourakis MI, Georgiou L, Anastasiadis P.

Histopathology. 2002 Jan;40(1):92-100.

PMID:
11903603
20.

Supplemental Content

Support Center